• QbDVision

  Participated · Series A · Feb 2022

  QbDVision offers a purpose-built Digital CMC (Chemistry, Manufacturing, and Controls) platform that structures, curates, and links CMC data across the product lifecycle to create a unified knowledge asset. The cloud-based platform is designed to replace siloed, document-centric workflows and to automate key development and tech-transfer processes, providing real-time guidance for data-driven decision making. Customers include three of the top six global pharma and biotech companies, and the product is positioned to improve regulatory readiness and reduce cycle times. The company emphasizes enabling AI-driven innovation by delivering trustworthy, highly contextualized CMC knowledge needed for predictive CMC models. QbDVision intends to expand commercial operations and accelerate adoption of Digital CMC as a strategic knowledge foundation for drug development and manufacturing. QbDVision offers a cloud-based digital CMC workspace designed to enhance the curation, utilization, and integrity of process development data. The platform creates a structured digital framework for integrating CMC workflows, embedding best practices for process design, and managing product and process knowledge. Developed by a team of drug development experts, the solution aims to accelerate therapies to patients by improving data and workflow management. The company serves a commercial market that already includes enterprise pharma, biotech, and CDMO customers across the world. Led by CEO Yash Sabharwal and based in Austin, TX, QbDVision plans to use recent funding to drive expansion of its commercial market. Financially, the company has raised a total of $20M to date. CherryCircle Software develops cloud-based software to manage the development of complex manufacturing processes in regulated industries, with a flagship product, QbDVision, focused on the pharmaceutical sector. QbDVision applies quality-by-design principles and is aligned with ISPE’s Pharma 4.0 initiatives. The company released an Americana version of QbDVision in September 2018 and reports immediate adoption. CherryCircle is ramping up sales and marketing activities to grow its customer base. The company plans to use proceeds from its seed financing to hire staff, expand its platform, and scale customer operations. CherryCircle was founded in 2016 by Yash Sabharwal and Ryan Shillington and is based in Austin, Texas.

• Accordion Health

  Participated · Seed · Feb 2019

  CherryCircle Software offers QbDVision, a cloud platform that applies quality-by-design principles to manage complex pharmaceutical manufacturing development and reduce development time and systemic failure risk. The company uses serverless technologies and automated testing tools to enable rapid development and deployment of secure, validated software solutions that support process and data management with strong data integrity. Its product is aimed at increasingly complex drug-manufacturing workflows, including emerging cell and gene therapies, and is designed to collect and interpret data from multiple sources. CherryCircle emphasizes capturing development knowledge over time and driving development decisions with data rather than documents. The company is an active member of the International Society for Pharmaceutical Engineering (ISPE). CherryCircle raised $2.3 million in seed funding to support growth plans.

No current team members are available.